Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 17, 2025 06:00 ET | Source: PathMaker Neurosystems Inc.

PathMaker Neurosystems Receives FDA Breakthrough Device Designation For Use of the MyoRegulator® Neuromodulation Device in ALS For Slowing the Progression of Functional Symptoms

PathMaker Neurosystems Receives FDA Breakthrough Device Designation For Non-Invasive Treatment of ALS Using the MyoRegulator® Neuromodulation Device
December 11, 2025 12:29 ET | Source: AB Science

AB Science annonce une nouvelle publication sur Medrxiv mettant en évidence le bénéfice clinique du masitinib chez les patients atteints de Sclérose Latérale Amyotrophique avant toute perte complète de fonction

COMMUNIQUÉ DE PRESSE AB SCIENCE ANNONCE UNE NOUVELLE PUBLICATION SUR MEDRXIV METTANT EN ÉVIDENCE LE BÉNÉFICE CLINIQUE DU MASITINIB CHEZ LES PATIENTS ATTEINTS DE SCLÉROSE LATÉRALE AMYOTROPHIQUE AVANT...
December 11, 2025 12:29 ET | Source: AB Science

AB Science announces new publication on Medrxiv highlighting clinical benefit with masitinib in Amyotrophic Lateral Sclerosis patients prior any complete loss of function

PRESS RELEASE AB SCIENCE ANNOUNCES NEW PUBLICATION ON MEDRXIV HIGHLIGHTING CLINICAL BENEFIT WITH MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS PATIENTS PRIOR ANY COMPLETE LOSS OF FUNCTION Significant...
December 04, 2025 08:00 ET | Source: BTT Medical Institute

BTT Medical Institute Announces Unprecedented Case of Total Reversal of ALS through Re-engineering of the Nobel Prize-Winning Fever Therapy into a Brain-Guided, Artificial Intelligence-Controlled ThermoFebrile Treatment

MIAMI, Dec. 04, 2025 (GLOBE NEWSWIRE) -- BTT Medical Institute, in collaboration with btt Corp. (Brain Tunnelgenix Technologies Corp.), a medical technology company pioneering brain thermodynamics...
December 03, 2025 09:00 ET | Source: Muscular Dystrophy Association

Muscular Dystrophy Association Announces nearly $2 Million in Collaborative Research Grants Advancing Treatments Across Multiple Neuromuscular Diseases

New York, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced the awarding of seven new collaborative research grants totaling nearly $2 million to advance...
December 01, 2025 09:00 ET | Source: Muscular Dystrophy Association

In Honor of His Mother Helen, Beauty Expert Ken Paves Partners with the Muscular Dystrophy Association to Raise $5 Million for ALS Fund

New York, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced the launch of The Helen Paves Fund for Care and a Cure, an endowed fund created in collaboration...
July 07, 2025 05:00 ET | Source: PathMaker Neurosystems Inc.

PathMaker Neurosystems Announces Publication of First Study Demonstrating Increased Survival in an ALS Mouse Model After Treatment With Non-Invasive Neuromodulation

PathMaker Announces Publication of First Study Demonstrating Increased Survival in an ALS Mouse Model After Treatment With Non-Invasive Neuromodulation
June 24, 2025 08:00 ET | Source: PharmaTher Holdings Ltd.

PharmaTher Secures Key US Patent for Ketamine in Amyotrophic Lateral Sclerosis (ALS), Bolstering its Orphan Drug Designated Program and Targeting a Billion Dollar Market

TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("PharmaTher" or the "Company"), a company focused on unlocking the pharmaceutical potential of...
June 02, 2025 13:00 ET | Source: PathMaker Neurosystems Inc.

PathMaker Neurosystems Announces Rhode Island Life Sciences Hub (RILSH) Funding to Establish Operations in Rhode Island

BOSTON, MA and PROVIDENCE, RI, June 02, 2025 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach...
April 29, 2025 09:00 ET | Source: Muscular Dystrophy Association

Muscular Dystrophy Association Launches National ALS Awareness Campaign to Accelerate the Search for a Cure

New York, April 29, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced the launch of its nationwide campaign focused on amyotrophic lateral sclerosis (ALS) during ALS...